Transformation of nanoparticles into compacts: A study on PLGA and celecoxib nanoparticles
Oral delivery of nanoparticles possesses many advantages for delivery of active pharmaceutical ingredients (APIs) to the gastrointestinal tract. However, the poor physical stability of nanoparticles in liquid state is often a challenge. Removing water from the nanosuspensions and transforming the nanoparticles into solid particulate matter in the form of, e.g., tablets could be a potential approach to increase the stability of nanoparticles. The aim of this study was to transform nanoparticles into compacts and to investigate the redispersion of nanoparticles from compacts as well as the dissolution behavior of these compacts. DL-lactide-co-glycolide copolymer (PLGA) nanoparticles and celecoxib (CLX) nanoparticles were used as two model nanoparticle systems and fabricated into nano-embedded microparticles (NEMs) and subsequently compressed into compacts.
The compacts were evaluated with respect to the redispersibility of the nanoparticles, as well as the dissolution characteristics of CLX. The results showed that the NEMs could be readily compressed into compacts with sufficient mechanical strength. The size of the redispersed PLGA nanoparticles from the compacts using 2-hydroxypropyl-β-cyclodextrin (HPβCD) as stabilizer was comparable to the original nanoparticles. In contrast, the redispersibility of CLX nanoparticles from the compacts was not as effective as for the PLGA nanoparticles evidenced by a significant increase in the size and polydispersity index (PDI) of the redispersed nanoparticles.
Nonetheless, an obvious enhancement in dissolution rate of CLX was observed from the compacts with CLX nanoparticles. It is concluded that transforming polymeric nanoparticles into compacts via NEMs provides stabilization and allows redispersion into original nanoparticles. Despite the reduced redispersibility, compacts loaded with nanoparticles exhibited improved dissolution rate compared with the crystalline drug. Loading of nanoparticles into compacts is a promising approach to overcome the poor stability of nanoparticle within oral drug delivery of nanoparticles.
Download the research paper as PDF: Transformation of nanoparticles into compacts
Yongquan Li, Minshu Li, Jukka Rantanen, Mingshi Yang, Adam Bohr,
Transformation of nanoparticles into compacts: A study on PLGA and celecoxib nanoparticles,
International Journal of Pharmaceutics, Volume 611, 2022, 121278, ISSN 0378-5173,
https://doi.org/10.1016/j.ijpharm.2021.121278.
Materials:
DL-lactide-co-glycolide copolymer (PLGA, PURASORB® PDLG) was purchased from Corbion (Amsterdam, the Netherlands). Celecoxib (CLX) was acquired from Dr. Reddy’s Laboratories Ltd. (Hyderabad, India). 2-hydroxypropyl-β-cyclodextrin (HPβCD) were purchased from Sigma-Aldrich (Copenhagen, Denmark). Kollidon VA64 (PVPVA) was obtained from BASF (Ludwigshafen, Germany). Silicified microcrystalline cellulose (SMCC) and sodium starch glycolate (SSG) was purchased from JRS PHARMA (Rosenberg, Germany).